Study finds new treatment to reverse inflammation and arterial blockages in rheumatoid arthritis
Researchers from the Queen Mary University of London have found that the molecule RvT4 enhances the body’s natural defenses against atherosclerosis (hardening of the arteries) in patients with rheumatoid arthritis. Studies in mice undertaken by researchers from Queen Mary University of London’s William Harvey Research Institute and Centre for Inflammation and Therapeutic Innovation and funded …
